Introduction: This is the 2016 Annual Report of the University of Kansas Health System Poison Control Center (PCC). The PCC is one of 55 certified poison control centers in the United States and serves the state of Kansas 24-hours a day, 365 days a year, with certified specialists in poison information and medical toxicologists. The PCC receives calls from the public, law enforcement, health care professionals, and public health agencies. All calls to the PCC are recorded electronically in the Toxicall® data management system and uploaded in near real-time to the National Poison Data System (NPDS), which is the data repository for all poison control centers in the United States.
Introduction

This is the 2016 Annual Report of University of Kansas Health System Poison Control
Center (PCC). The PCC is a 24-hour 365 day/year health care information resource serving the state of Kansas. It was founded in 1982 and is certified with the American Association of Poison Control Centers (AAPCC). Currently, there are 55 certified poison control centers in the United States. The PCC is staffed by 10 certified specialists in poison information who are either critical care trained nurses or doctors of pharmacy. There is 24-hour back up provided by board certified medical toxicologists. The PCC receives calls from the public, law enforcement, health care professionals, and public health agencies. Encounters may involve an exposed animal or human (Exposure Call) or a request for information with no known exposure (Information Call). The PCC follows all cases to make management recommendations, monitor case progress, and document medical outcome. This information is recorded electronically in the Toxicall® data management system and uploaded in near real-time to the National Poison Data System (NPDS). NPDS is the data warehouse for all of the nation's poison control centers. 1 The NPDS utilizes a products database that contains over 427,000 products to classify exposures. The database is maintained and updated continuously by data analysts at the Micromedex Poisindex® System. 1 The average time to upload data for all PCs is 9.52 minutes, creating a real-time national exposure database and surveillance system. 1 The PCC has the ability to share NPDS real time surveillance with state and local health departments and other regulatory agencies. What follows is analysis and summary of all encounters reported to the PCC from January 1, 2016 to December 31, 2016.
Methods
All PCC encounters recorded electronically in the Toxicall® data management system from January 1, 2016 to December 31, 2016 were analyzed. Cases were first classified as either an exposure or suspected exposure (Human Exposure, Animal Exposure, Non-Exposure
Confirmed Cases) or a request for information with no reported exposure (Information Call).
Data extracted includes caller location, age, weight, gender, exposure substance, number of follow-up calls, and nature of exposure (i.e., unintentional, recreational, or intentional).
Additional data collected included exposure scenario, route of exposure (oral, dermal, parenteral), interventions, medical outcome (no effect, minor, moderate, severe, or death), disposition (admitted to noncritical care unit, admitted to critical care unit, admitted to psychiatry unit, lost to follow-up, or treated and released) and location of care (non-health care facility or health care facility). For this analysis, a pediatric case was defined as any patient 19 years of age or less. This is consistent with NPDS methodology. For medical outcome, the following definitions were used: minor -minimally bothersome symptoms, moderate -more pronounced symptoms, usually requiring treatment, and major life threatening signs and symptoms.
Data were analyzed using Microsoft Excel (Microsoft Corp, Redmond, WA).
Results
The PCC logged 21,965 total calls in 2016, including 20,713 human exposure cases, 87
non-exposure confirmed cases, 112 animal exposure cases, and 1,053 information calls. For information calls, drug information (n = 308) was most common reason for calling. Table 1 further describes the encounter types. The PCC made 32,137 follow-up calls in 2016. Follow-up calls were done in 60.9% of human exposure cases. One follow-up call was made in 29.5% of human exposure cases and multiple follow-up calls (range 2 -44) were made in 31.3% of cases.
In human exposure calls for which follow-up calls were made, an average of 2.54 follow-up calls per case were performed. The majority of human exposure cases (50.4%, n = 10,174) were female. A male predominance was found among encounters involving children younger than 13 years of age, but this gender distribution was reversed in teenagers and adults, with females comprising the majority of reported exposures. Approximately 67% (n = 13,903) of human exposures involved a child (defined as age 19 years or less). Table 2 illustrates distribution of human exposures by age and gender. Figure 1 demonstrates that patients 1 year of age were the most common age group involved in encounters reported to the PCC. For adults, the age group of 20 -29 years old was encountered most commonly ( Figure 2 The majority of human exposures (n = 18,233) were acute cases (exposures occurring over eight hours or less). Chronic exposures (exposures occurring > 8 hours) accounted for 1.6%
(327) of all human exposures reported. Acute on chronic exposures (single exposure that was preceded by a chronic exposure > 8 hours) totaled 2063 (9.96%). Ingestion was the most common route of exposure documented (86.3%, n = 17,882) in all cases (Table 4) . The most common reported substance in those less than 5 years of age was cosmetics/personal care products (n = 1,362) followed closely by household cleaning products (n = 1,301). For adult (> 20 years of age) encounters, sedatives/hypnotics/antipsychotics (n = 1,130) and analgesics (n = 1,103) were the most frequently involved substances. Among all encounters, analgesics (n = 2,813, 11%) were the most frequently encountered substance category. Table 5 lists most frequently encountered substance categories for pediatric encounters and There were a total of 399 plant exposures reported to the PCC. The most common plant exposure encountered was to pokeweed (Phytolacca Americana; n = 48). Table 7 lists the top 5 most encountered plants. 
Philodendron (Species unspecified) 16
Cherry (Species unspecified) 12
Unintentional exposures were the most common reason for exposures (81.3%, n = 16,836) while intentional exposures accounted for 16.3% (n = 3,377) of exposures. Table 8 lists reasons for human exposures. A majority of unintentional exposures (n = 10,897) occurred in the 11 | P a g e less than 5 years old age group. Up to age 12, 98.9% (n = 12,171) of ingestions were unintentional. However, in the 13 -19 year-old group, intentional exposure was most common (63.1%, n = 1,087). In total, suspected suicide attempts accounted for 11.7% (n = 2,415) of human encounters. When a therapeutic error was the reason for exposure, a double dose was the most common scenario (n = 775). Most encounters (71.1%, n = 14,732) were managed in a non-health care facility (i.e., a residence). Of the 5,747 encounters managed at a health care facility, 42% (n = 2419) were admitted. Table 9 lists the management site of all human encounters. Among human exposures, 14,679 involved exposures to pharmaceutical agents, while 10,176 involved exposure to non-pharmaceuticals. Because an encounter could include both a pharmaceutical agent and non-pharmaceutical agent, this total is greater than the total number of encounters. However, 88.5% (n = 18,327) of all human exposures were exposed to only a single substance. Among these single substance exposures, the reason for exposure was intentional in 19.3% (n = 3,527) of pharmaceutical-only cases compared to 3.5% (n = 641) of nonpharmaceutical single substance exposures.
When medical outcomes were analyzed, 32% (n = 6,582) of human exposures had no effect, 19% (n = 3,911) had minor effect, 8% (n = 1,623) had moderate effect, and 2% (n = 348) major effects. Moderate and major effects were more common in those over 20 years of age and in those with intentional encounters. More serious outcomes were related to single-substance pharmaceutical exposures, accounting for 66.7% (n = 10) of the fatalities. Table 10 lists all   medical outcomes by age and Table 11 lists them by reason for exposure. Total 10,930 100.00 1,241 100.00 1,723 100.00 6,584 100.00 9 100.00 129 100.00 97 100.00 20,713 100.00 Table 11 . Medical outcome by reason for exposure in human exposures.
Use of decontamination and specific therapies, including antidotal therapy, is detailed in Tables 12a and 12b . Table 12b . Therapy provided in human exposures by age. The ongoing importance of the PCC is reflected in current trends that have seen rates of poisonings and overdoses increase at an alarming rate. The PCC saw an increase in number of calls from healthcare facilities, cases with moderate or major medical outcomes and deaths in 2016 compared to 2015. In an August 2017 report, the National Center for Health Statistic noted that the age-adjusted drug-poisoning death rate increased from 6.1 per 100,000 in 1999 to 16.3 per 100,000 in 2015, totaling over 50,000 deaths in 2015.
3 Teenage (age 15 -19) overdose deaths are increasing as well. 4 The ongoing "opioid epidemic" is a major driver in the rise of poisoning deaths. 
Conclusion
The results of the 2016 University of Kansas Health System Poison Control annual report demonstrated that the center receives calls from the entire state of Kansas, totaling over 20,000
human exposures per year. While pediatric exposures remain the most common, there is an increasing number of calls from healthcare facilities and for cases with serious outcomes. The experience of the PCC is similar to national data. This report supports the continued value of the PCC to both public and acute health care in the state of Kansas.
